328 related articles for article (PubMed ID: 32181476)
1. KRT84 is a potential tumor suppressor and good prognosis signature of oral squamous cell carcinoma.
Liu Y; Li R; Ren G
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32181476
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
[No Abstract] [Full Text] [Related]
3. Predicting the Presence of Oral Squamous Cell Carcinoma Using Commonly Dysregulated MicroRNA in Oral Swirls.
Yap T; Koo K; Cheng L; Vella LJ; Hill AF; Reynolds E; Nastri A; Cirillo N; Seers C; McCullough M
Cancer Prev Res (Phila); 2018 Aug; 11(8):491-502. PubMed ID: 29764807
[TBL] [Abstract][Full Text] [Related]
4. Relationship between p16 expression and prognosis in different anatomic subsites of OSCC.
Ni Y; Zhang X; Wan Y; Dun Tang K; Xiao Y; Jing Y; Song Y; Huang X; Punyadeera C; Hu Q
Cancer Biomark; 2019; 26(3):375-383. PubMed ID: 31594213
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of JAG2 is related to poor outcomes in oral squamous cell carcinoma.
Hatano K; Saigo C; Kito Y; Shibata T; Takeuchi T
Clin Exp Dent Res; 2020 Apr; 6(2):174-180. PubMed ID: 32250571
[TBL] [Abstract][Full Text] [Related]
7. MiR-610 functions as a tumor suppressor in oral squamous cell carcinoma by directly targeting AGK.
Yao LX; Liu J; Xu L
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):187-197. PubMed ID: 30657560
[TBL] [Abstract][Full Text] [Related]
8. Role of hyaluronan mediated motility receptor gene in oral squamous cell carcinoma and clinical prognosis.
Tang Y; Xiao Y; Liao R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1315-1324. PubMed ID: 35232899
[TBL] [Abstract][Full Text] [Related]
9. Tissue mechanics and expression of TROP2 in oral squamous cell carcinoma with varying differentiation.
Zhang B; Gao S; Li R; Li Y; Cao R; Cheng J; Guo Y; Wang E; Huang Y; Zhang K
BMC Cancer; 2020 Aug; 20(1):815. PubMed ID: 32854652
[TBL] [Abstract][Full Text] [Related]
10. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-625-3p promotes cell migration of oral squamous cell carcinoma by regulating SCAI expression.
Xu D; Gu M; Liu HL
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):641-648. PubMed ID: 30720172
[TBL] [Abstract][Full Text] [Related]
12. Identification of diagnostic and prognostic lncRNA biomarkers in oral squamous carcinoma by integrated analysis and machine learning.
Yang S; Wang Y; Ren J; Zhou X; Cai K; Guo L; Wu S
Cancer Biomark; 2020; 29(2):265-275. PubMed ID: 32716346
[TBL] [Abstract][Full Text] [Related]
13. High ACTN1 Is Associated with Poor Prognosis, and ACTN1 Silencing Suppresses Cell Proliferation and Metastasis in Oral Squamous Cell Carcinoma.
Xie GF; Zhao LD; Chen Q; Tang DX; Chen QY; Lu HF; Cai JR; Chen Z
Drug Des Devel Ther; 2020; 14():1717-1727. PubMed ID: 32440097
[TBL] [Abstract][Full Text] [Related]
14. High expression of Rab31 confers a poor prognosis and enhances cell proliferation and invasion in oral squamous cell carcinoma.
Li X; Zhu F; Liu Z; Tang X; Han Y; Jiang J; Ma C; He Y
Oncol Rep; 2021 Mar; 45(3):1182-1192. PubMed ID: 33469675
[TBL] [Abstract][Full Text] [Related]
15. Family with Sequence Similarity 72 (FAM72) - A prospective biomarker for poor prognosis in patients with oral squamous cell carcinoma.
Liu H; Huang Y; Chen Y; Tang Z; Huang M; Ming Y; Wang M; Chen W; Huang Z; Qing L; Wang Q; Jia B
Arch Oral Biol; 2023 Jul; 151():105695. PubMed ID: 37086493
[TBL] [Abstract][Full Text] [Related]
16. MiR-148a inhibits oral squamous cell carcinoma progression through ERK/MAPK pathway via targeting IGF-IR.
Jia T; Ren Y; Wang F; Zhao R; Qiao B; Xing L; Ou L; Guo B
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32202300
[TBL] [Abstract][Full Text] [Related]
17. Tumour mismatch repair protein loss is associated with advanced stage in oral cavity squamous cell carcinoma.
Vasan K; Satgunaseelan L; Anand S; Asher R; Selinger C; Low TH; Palme CE; Clark JR; Gupta R
Pathology; 2019 Dec; 51(7):688-695. PubMed ID: 31630878
[TBL] [Abstract][Full Text] [Related]
18. A Three Long Noncoding RNA-Based Signature for Oral Squamous Cell Carcinoma Prognosis Prediction.
Zhao C; Zou H; Wang J; Shen J; Liu H
DNA Cell Biol; 2018 Nov; 37(11):888-895. PubMed ID: 30234381
[TBL] [Abstract][Full Text] [Related]
19. Activin A triggers angiogenesis via regulation of VEGFA and its overexpression is associated with poor prognosis of oral squamous cell carcinoma.
Ervolino De Oliveira C; Dourado MR; Sawazaki-Calone Í; Costa De Medeiros M; Rossa Júnior C; De Karla Cervigne N; Esquiche León J; Lambert D; Salo T; Graner E; Coletta RD
Int J Oncol; 2020 Jul; 57(1):364-376. PubMed ID: 32377747
[TBL] [Abstract][Full Text] [Related]
20. PBK Expression Is Associated With Prognosis of Patients With Oral Squamous Cell Carcinoma Treated With Radiotherapy: A Retrospective Study.
Yu WN; Lin HF; Lee YI; Shia WC; Sung WW; Yeh CM; Lin YM
Anticancer Res; 2021 Apr; 41(4):2177-2182. PubMed ID: 33813430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
